LEGRAND, M., P.O. LUDES, Z. MASSY, P. ROSSIGNOL, Jiří PAŘENICA, J.J. PARK, S. ISHIHARA, K.F. ALHABIB, A. MAGGIONI, O. MIRO, N. SATO, A. COHEN-SOLAL, E. FAIRMAN, J. LASSUS, V.P. HARJOLA, C. MUELLER, F. PEACOCK, D.J. CHOI, P. PLAISANCE, Jindřich ŠPINAR, M. KOSIBOROD, A. MEBAZAA and E. GAYAT. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clinical Research in Cardiology. Heidelberg: Springer, 2018, vol. 107, No 3, p. 214-221. ISSN 1861-0684. Available from: https://dx.doi.org/10.1007/s00392-017-1173-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications
Authors LEGRAND, M. (250 France, guarantor), P.O. LUDES (250 France), Z. MASSY (250 France), P. ROSSIGNOL (250 France), Jiří PAŘENICA (203 Czech Republic, belonging to the institution), J.J. PARK (410 Republic of Korea), S. ISHIHARA (392 Japan), K.F. ALHABIB (682 Saudi Arabia), A. MAGGIONI (380 Italy), O. MIRO (724 Spain), N. SATO (392 Japan), A. COHEN-SOLAL (250 France), E. FAIRMAN (32 Argentina), J. LASSUS (246 Finland), V.P. HARJOLA (246 Finland), C. MUELLER (756 Switzerland), F. PEACOCK (840 United States of America), D.J. CHOI (410 Republic of Korea), P. PLAISANCE (250 France), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), M. KOSIBOROD (840 United States of America), A. MEBAZAA (250 France) and E. GAYAT (250 France).
Edition Clinical Research in Cardiology, Heidelberg, Springer, 2018, 1861-0684.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.907
RIV identification code RIV/00216224:14110/18:00103657
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00392-017-1173-3
UT WoS 000425730100003
Keywords in English Mortality; Potassium; B-blockers; Heart failure; Renal failure
Tags 14110211, EL OK, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2019 20:41.
Abstract
Background The interaction between chronic medications on admission and the association between serum potassium level and outcome in patients with acute heart failure (AHF) are unknown. Methods Observational intercontinental study of patients admitted with AHF. 15954 patients were included from 12 cohorts in 4 continents. Main outcome was 90-day mortality. Clinical presentation (medication use, hemodynamics, comorbidities), demographic, echocardiographic, and biochemical data on admission were recorded prospectively in each cohort, with prospective adjudication of outcomes. Results Positive and negative linear relationships between 90-day mortality and sK+ above 4.5 mmol/L (hyperkalemia) and below 3.5 mmol/L (hypo-kalemia) were observed. Hazard ratio for death was 1.46 [1.34-1.58] for hyperkalemia and 1.22 [1.06-1.40] for hypokalemia. In a fully adjusted model, only hyperkalemia remained associated with mortality (HR 1.03 [1.02-1.04] for each 0.1 mmol/l change of sK+ above 4.5 mmol/L). Interaction tests revealed that the association between hyperkalemia and outcome was significantly affected by chronic medications. The association between hyperkalemia and mortality was absent for patients treated with beta blockers and in those with preserved renal function. Conclusions In patients with AHF, sK+ > 4.5 mmol/L appears to be associated with 90-day mortality. B-blockers have potentially a protective effect in the setting of hyperkalemia.
PrintDisplayed: 26/4/2024 21:42